Establishment— Not later than 90 days after the date of enactment of this Act, the Secretary shall establish an initiative, to be known as the “extremophile whole genome sequencing initiative”, that shall—
be consistent with the goals of the Genesis Mission announced in Executive Order 14363 (90 Fed. Reg. 55035; relating to launching the Genesis Mission); and
facilitate the collection of new genomic data that will contribute to advances in scientific discovery and may support the development of new healthcare treatments.
collect, catalogue, and sequence the whole genomes and metabolites of samples from animals, plants, fungi, and microbes found in locations selected under paragraph (3);
establish a database for the data collected under subparagraph (A), or use an existing database, such as the database of the National Center for Biotechnology Information, including sequence data, genome assemblies, peptides, metabolite data, annotations, and associated metadata, including genome and transcriptome data, metabolome data, and proteome data;
collaborate with industry, academia, and other government agencies to collate existing relevant data for inclusion in the database established or used under subparagraph (B);
make that database accessible to persons in the United States, subject to the condition that the Secretary shall, to the maximum extent practicable, prevent the sharing of such information with adversary nations or foreign persons; and
in such a manner that the facility may continue to operate in the case of a catastrophic incident (as defined in section 602 of the Post-Katrina Emergency Management Reform Act of 2006 (6 U.S.C. 701)).
Third party collection— The Secretary may enter into contracts with third party entities, including institutions of higher education or private sector entities, to collect samples under paragraph (1)(A).
In general— Not later than 180 days after the date of enactment of this Act, the Secretary shall select not fewer than 5 locations from which to collect samples under paragraph (1)(A), at least 1 of which shall be a mine or former mine that—
that may support the development of new healthcare treatments relating to cancer, including cancers affecting children and individuals with high mortality rates, diabetes, and dementia, including Alzheimer’s disease.
Preference— In selecting locations under subparagraph (A), the Secretary may give preference to a location on land owned or controlled by the Department of Energy (including National Laboratories).
Range of extreme conditions— In selecting locations under subparagraph (A), the Secretary shall ensure that the locations reflect a broad range of extreme conditions.
Long-term storage facility— In selecting a location for the covered facility under the plan developed under paragraph (1)(E), the Secretary shall consider, among other factors determined relevant by the Secretary—
if there are no applicable Federal data standards described in subclause (I), meet data standards for the initiative established by the Secretary, in consultation with the National Institute of Standards and Technology and other relevant agencies, based on findability, accessibility, interoperability, and reusability data principles and using industry best practices; and
ensure that appropriate cybersecurity and access safeguards are implemented to protect the data generated or stored under the initiative, including by ensuring that data outputs under the initiative are updated as necessary to meet applicable Federal cybersecurity standards for genomic data, including controls consistent with the National Institute of Standards and Technology special publications 800–53 (relating to Security and Privacy Controls for Information Systems and Organizations) and 800–111 (relating to Guide to Storage Encryption Technologies for End User Devices) or any successor framework.
Long-term storage requirements— The Secretary may consult with the Secretary of Agriculture and the Director of the National Museum of Natural History of the Smithsonian Institution with respect to storage capabilities for the management and long-term storage of samples collected under the initiative, subject to the following:
Any physical storage, curation, and laboratory processing of samples collected under the initiative shall occur within facilities located in the United States.
collaborate with the Secretary of Agriculture, the Director of the National Museum of Natural History of the Smithsonian Institution, and the heads of other applicable Federal agencies to sequence genomic information from samples collected under the initiative;
Termination of collection— No collection of samples under paragraph (1)(A) may occur by the Secretary or a third party pursuant to a contract entered into under paragraph (2) after the date that is 5 years after the date of enactment of this Act.
the Department of Health and Human Services, including the Centers for Disease Control and Prevention and the National Institutes of Health, including the Childhood Cancer Data Initiative;
nonprofit organizations, including organizations focused on the collection of data for the discovery of treatments for cancer, diabetes, and dementia, including Alzheimer’s disease;
nonprofit organizations that support biodiversity conservation, including nonprofit organizations in allied countries described in subsection (e)(2); and
Private sector contributions— There shall be established a foundation, which shall be an organization described in section 501(c)(3) of the Internal Revenue Code of 1986 and exempt from taxation under section 501(a) of that Code, to receive in-kind contributions from biotechnology and other private sector companies to assist in carrying out the initiative and supporting the operation of the covered facility.
In general— The Secretary shall establish a working group to coordinate with private and public sector initiatives in the United States and allied countries described in paragraph (2) collecting relevant genomic data to create alignment between scientific groups—